B
Exchange
—
Entity type
operating
Fiscal year end
Jun 30
Headquarters
DE
Recent Filings
- SC 13D/A143.8 KBBIOENVISION INCOct 1, 9:16 AM ET·0000950136-07-006779
- 8-K36.8 KBBIOENVISION INCAug 16, 1:28 PM ET·0001104659-07-063037
- 8-K16.5 KBBIOENVISION INCJul 30, 9:52 AM ET·0001104659-07-057030
- 424.8 KBBIOENVISION INCJul 12, 6:48 PM ET·0000950142-07-001594
- SC 13D/A46.6 KBBIOENVISION INCJul 12, 5:26 PM ET·0000950142-07-001590
- 45.3 KBBIOENVISION INCJul 12, 12:19 PM ET·0001116679-07-001828
- 45.3 KBBIOENVISION INCJul 12, 12:13 PM ET·0001116679-07-001826
- 45.3 KBBIOENVISION INCJul 12, 12:11 PM ET·0001116679-07-001824
- 45.3 KBBIOENVISION INCJul 12, 12:07 PM ET·0001116679-07-001822
- SC 13D/A98.0 KBBIOENVISION INCJul 3, 6:09 AM ET·0000950136-07-004627
Insiders
10- Abercrombie IanSales Director, Europe
- GENZYME CORP10% Owner
- LUCI DAVID PEVP & General Counsel
- Nelson Thomas ScottDirector
- PERSEUSPUR LLC10% Owner
- PERSEUS SOROS BIOPHARMACEUTICAL FUND LP10% Owner
- PERSEUS SOROS PARTNERS LLC10% Owner
- Rouhandeh Steven H10% Owner
- SCO CAPITAL PARTNERS LLC10% Owner
- SFM PARTICIPATION LP10% Owner
Tickers
No tickers on record
Addresses
business
345 PARK AVENUE 41ST FLOOR
NEW YORK, NY, 10154
mailing
345 PARK AVENUE 41ST FLOOR
NEW YORK, NY, 10154
Former Names
- ASCOT GROUP INC1999-01-12